ArticleKidney international reports2023

Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD.

Sachin Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.